nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolterodine—CHRM2—type 1 diabetes mellitus	0.913	1	CbGaD
Tolterodine—Fesoterodine—CHRM2—type 1 diabetes mellitus	0.00261	0.39	CrCbGaD
Tolterodine—Disopyramide—CHRM2—type 1 diabetes mellitus	0.00117	0.174	CrCbGaD
Tolterodine—Labetalol—ADRB1—type 1 diabetes mellitus	0.00111	0.165	CrCbGaD
Tolterodine—Brompheniramine—CHRM2—type 1 diabetes mellitus	0.000867	0.13	CrCbGaD
Tolterodine—Orphenadrine—CHRM2—type 1 diabetes mellitus	0.000546	0.0816	CrCbGaD
Tolterodine—Phenprocoumon—ALB—type 1 diabetes mellitus	0.000392	0.0586	CrCbGaD
Tolterodine—Anaphylactoid reaction—Ramipril—type 1 diabetes mellitus	5.05e-05	0.0588	CcSEcCtD
Tolterodine—Bronchitis—Ramipril—type 1 diabetes mellitus	4.06e-05	0.0473	CcSEcCtD
Tolterodine—Upper respiratory tract infection—Ramipril—type 1 diabetes mellitus	3.92e-05	0.0457	CcSEcCtD
Tolterodine—Weight increased—Ramipril—type 1 diabetes mellitus	3.84e-05	0.0447	CcSEcCtD
Tolterodine—Urinary tract infection—Ramipril—type 1 diabetes mellitus	3.66e-05	0.0426	CcSEcCtD
Tolterodine—Sinusitis—Ramipril—type 1 diabetes mellitus	3.53e-05	0.0411	CcSEcCtD
Tolterodine—CHRM1—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	3.4e-05	0.000426	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	3.39e-05	0.000426	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	3.38e-05	0.000425	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	3.36e-05	0.000422	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	3.35e-05	0.000421	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	3.35e-05	0.00042	CbGpPWpGaD
Tolterodine—Oedema peripheral—Ramipril—type 1 diabetes mellitus	3.33e-05	0.0388	CcSEcCtD
Tolterodine—CHRM1—Signaling by GPCR—GCG—type 1 diabetes mellitus	3.31e-05	0.000415	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—GCG—type 1 diabetes mellitus	3.3e-05	0.000414	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—G6PC2—type 1 diabetes mellitus	3.29e-05	0.000413	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—GCG—type 1 diabetes mellitus	3.26e-05	0.00041	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—G6PC2—type 1 diabetes mellitus	3.26e-05	0.00041	CbGpPWpGaD
Tolterodine—Visual impairment—Ramipril—type 1 diabetes mellitus	3.26e-05	0.0379	CcSEcCtD
Tolterodine—CHRM4—Signaling Pathways—SST—type 1 diabetes mellitus	3.25e-05	0.000408	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—ADRB1—type 1 diabetes mellitus	3.24e-05	0.000407	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—GAL—type 1 diabetes mellitus	3.2e-05	0.000402	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—GAL—type 1 diabetes mellitus	3.19e-05	0.0004	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	3.18e-05	0.0004	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—ITPR3—type 1 diabetes mellitus	3.18e-05	0.0004	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	3.17e-05	0.000399	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CCL20—type 1 diabetes mellitus	3.16e-05	0.000397	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CCL11—type 1 diabetes mellitus	3.16e-05	0.000397	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—GAL—type 1 diabetes mellitus	3.16e-05	0.000397	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CCL20—type 1 diabetes mellitus	3.15e-05	0.000396	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CCL11—type 1 diabetes mellitus	3.15e-05	0.000396	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	3.14e-05	0.000395	CbGpPWpGaD
Tolterodine—Flushing—Ramipril—type 1 diabetes mellitus	3.14e-05	0.0365	CcSEcCtD
Tolterodine—CHRM2—Signaling Pathways—CCL20—type 1 diabetes mellitus	3.12e-05	0.000392	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CCL11—type 1 diabetes mellitus	3.12e-05	0.000392	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—SST—type 1 diabetes mellitus	3.11e-05	0.000391	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—ABCC8—type 1 diabetes mellitus	3.1e-05	0.000389	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—ADRB1—type 1 diabetes mellitus	3.1e-05	0.000389	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—VAV1—type 1 diabetes mellitus	3.09e-05	0.000388	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	3.08e-05	0.000387	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—VAV1—type 1 diabetes mellitus	3.08e-05	0.000387	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	3.07e-05	0.000386	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—VAV1—type 1 diabetes mellitus	3.05e-05	0.000383	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	3.04e-05	0.000382	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—HBA1—type 1 diabetes mellitus	3e-05	0.000376	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—APOC3—type 1 diabetes mellitus	2.98e-05	0.000374	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CHRM2—type 1 diabetes mellitus	2.97e-05	0.000373	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CHRM2—type 1 diabetes mellitus	2.96e-05	0.000372	CbGpPWpGaD
Tolterodine—CHRM1—Circadian rythm related genes—IL6—type 1 diabetes mellitus	2.96e-05	0.000372	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—GSTT1—type 1 diabetes mellitus	2.92e-05	0.000367	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—GCG—type 1 diabetes mellitus	2.9e-05	0.000364	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—ABCC8—type 1 diabetes mellitus	2.85e-05	0.000358	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—ABCC8—type 1 diabetes mellitus	2.83e-05	0.000355	CbGpPWpGaD
Tolterodine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 1 diabetes mellitus	2.81e-05	0.000352	CbGpPWpGaD
Tolterodine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 1 diabetes mellitus	2.8e-05	0.000351	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	2.79e-05	0.00035	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—GCG—type 1 diabetes mellitus	2.77e-05	0.000349	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—VAV1—type 1 diabetes mellitus	2.71e-05	0.00034	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—CXCL10—type 1 diabetes mellitus	2.7e-05	0.000339	CbGpPWpGaD
Tolterodine—Angioedema—Ramipril—type 1 diabetes mellitus	2.69e-05	0.0313	CcSEcCtD
Tolterodine—CHRM5—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	2.67e-05	0.000336	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—ITPR3—type 1 diabetes mellitus	2.67e-05	0.000335	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—ITPR3—type 1 diabetes mellitus	2.66e-05	0.000334	CbGpPWpGaD
Tolterodine—Vertigo—Ramipril—type 1 diabetes mellitus	2.64e-05	0.0308	CcSEcCtD
Tolterodine—CHRM2—Signaling Pathways—ITPR3—type 1 diabetes mellitus	2.64e-05	0.000331	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	2.63e-05	0.000331	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	2.62e-05	0.00033	CbGpPWpGaD
Tolterodine—Palpitations—Ramipril—type 1 diabetes mellitus	2.6e-05	0.0303	CcSEcCtD
Tolterodine—CHRM2—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	2.6e-05	0.000326	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	2.6e-05	0.000326	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—VAV1—type 1 diabetes mellitus	2.59e-05	0.000326	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CXCL10—type 1 diabetes mellitus	2.59e-05	0.000325	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	2.59e-05	0.000325	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	2.56e-05	0.000322	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—SH2B3—type 1 diabetes mellitus	2.51e-05	0.000316	CbGpPWpGaD
Tolterodine—Chest pain—Ramipril—type 1 diabetes mellitus	2.51e-05	0.0292	CcSEcCtD
Tolterodine—Arthralgia—Ramipril—type 1 diabetes mellitus	2.51e-05	0.0292	CcSEcCtD
Tolterodine—CHRM3—Signaling Pathways—SH2B3—type 1 diabetes mellitus	2.5e-05	0.000315	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—IAPP—type 1 diabetes mellitus	2.5e-05	0.000314	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—APOC3—type 1 diabetes mellitus	2.5e-05	0.000314	CbGpPWpGaD
Tolterodine—Anxiety—Ramipril—type 1 diabetes mellitus	2.5e-05	0.0291	CcSEcCtD
Tolterodine—CHRM3—Signaling Pathways—IAPP—type 1 diabetes mellitus	2.49e-05	0.000313	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—APOC3—type 1 diabetes mellitus	2.49e-05	0.000313	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—SH2B3—type 1 diabetes mellitus	2.48e-05	0.000312	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—APOC3—type 1 diabetes mellitus	2.46e-05	0.00031	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—IAPP—type 1 diabetes mellitus	2.46e-05	0.00031	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—TYK2—type 1 diabetes mellitus	2.46e-05	0.000309	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—IGF2—type 1 diabetes mellitus	2.45e-05	0.000308	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—KCNJ11—type 1 diabetes mellitus	2.45e-05	0.000308	CbGpPWpGaD
Tolterodine—Dry mouth—Ramipril—type 1 diabetes mellitus	2.45e-05	0.0285	CcSEcCtD
Tolterodine—Confusional state—Ramipril—type 1 diabetes mellitus	2.42e-05	0.0282	CcSEcCtD
Tolterodine—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	2.4e-05	0.028	CcSEcCtD
Tolterodine—Oedema—Ramipril—type 1 diabetes mellitus	2.4e-05	0.028	CcSEcCtD
Tolterodine—CHRM1—Signaling by GPCR—CCR5—type 1 diabetes mellitus	2.39e-05	0.0003	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—CCR5—type 1 diabetes mellitus	2.38e-05	0.000299	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—CD86—type 1 diabetes mellitus	2.36e-05	0.000297	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—CCR5—type 1 diabetes mellitus	2.36e-05	0.000296	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—TYK2—type 1 diabetes mellitus	2.36e-05	0.000296	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	2.36e-05	0.000296	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	2.35e-05	0.000295	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—IGF2—type 1 diabetes mellitus	2.35e-05	0.000295	CbGpPWpGaD
Tolterodine—Tachycardia—Ramipril—type 1 diabetes mellitus	2.34e-05	0.0273	CcSEcCtD
Tolterodine—CHRM3—Metabolism—GCG—type 1 diabetes mellitus	2.33e-05	0.000293	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	2.33e-05	0.000292	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—HBA2—type 1 diabetes mellitus	2.29e-05	0.000287	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CD86—type 1 diabetes mellitus	2.26e-05	0.000284	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—IL2—type 1 diabetes mellitus	2.26e-05	0.000283	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—KCNJ11—type 1 diabetes mellitus	2.25e-05	0.000283	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—E2F1—type 1 diabetes mellitus	2.24e-05	0.000282	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—KCNJ11—type 1 diabetes mellitus	2.23e-05	0.000281	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—SST—type 1 diabetes mellitus	2.19e-05	0.000275	CbGpPWpGaD
Tolterodine—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	2.19e-05	0.0255	CcSEcCtD
Tolterodine—CHRM3—Signaling Pathways—SST—type 1 diabetes mellitus	2.19e-05	0.000274	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—ADRB1—type 1 diabetes mellitus	2.18e-05	0.000274	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—ADRB1—type 1 diabetes mellitus	2.18e-05	0.000273	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—SST—type 1 diabetes mellitus	2.16e-05	0.000272	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—IL2—type 1 diabetes mellitus	2.16e-05	0.000271	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—ADRB1—type 1 diabetes mellitus	2.15e-05	0.000271	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—G6PC2—type 1 diabetes mellitus	2.15e-05	0.00027	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—E2F1—type 1 diabetes mellitus	2.15e-05	0.00027	CbGpPWpGaD
Tolterodine—Somnolence—Ramipril—type 1 diabetes mellitus	2.13e-05	0.0249	CcSEcCtD
Tolterodine—CHRM4—Signaling Pathways—ERBB3—type 1 diabetes mellitus	2.13e-05	0.000268	CbGpPWpGaD
Tolterodine—Dyspepsia—Ramipril—type 1 diabetes mellitus	2.11e-05	0.0246	CcSEcCtD
Tolterodine—CHRM4—Signaling Pathways—CCR5—type 1 diabetes mellitus	2.09e-05	0.000263	CbGpPWpGaD
Tolterodine—Fatigue—Ramipril—type 1 diabetes mellitus	2.07e-05	0.0241	CcSEcCtD
Tolterodine—CYP2C19—Metabolism—ITPR3—type 1 diabetes mellitus	2.07e-05	0.00026	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—IL2RA—type 1 diabetes mellitus	2.06e-05	0.000259	CbGpPWpGaD
Tolterodine—Constipation—Ramipril—type 1 diabetes mellitus	2.05e-05	0.0239	CcSEcCtD
Tolterodine—CHRM4—Signaling by GPCR—IL2—type 1 diabetes mellitus	2.05e-05	0.000257	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—ERBB3—type 1 diabetes mellitus	2.04e-05	0.000256	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CCR5—type 1 diabetes mellitus	2.01e-05	0.000252	CbGpPWpGaD
Tolterodine—Feeling abnormal—Ramipril—type 1 diabetes mellitus	1.98e-05	0.023	CcSEcCtD
Tolterodine—CHRM5—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.98e-05	0.000248	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—CAT—type 1 diabetes mellitus	1.97e-05	0.000248	CbGpPWpGaD
Tolterodine—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	1.96e-05	0.0229	CcSEcCtD
Tolterodine—CHRM5—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.96e-05	0.000246	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—GCG—type 1 diabetes mellitus	1.95e-05	0.000245	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—GCG—type 1 diabetes mellitus	1.95e-05	0.000245	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—HBA1—type 1 diabetes mellitus	1.95e-05	0.000245	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—APOC3—type 1 diabetes mellitus	1.94e-05	0.000243	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—GCG—type 1 diabetes mellitus	1.93e-05	0.000242	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—ITPR3—type 1 diabetes mellitus	1.9e-05	0.000239	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—GSTT1—type 1 diabetes mellitus	1.9e-05	0.000239	CbGpPWpGaD
Tolterodine—Abdominal pain—Ramipril—type 1 diabetes mellitus	1.9e-05	0.0221	CcSEcCtD
Tolterodine—CYP2C9—Metabolism—ITPR3—type 1 diabetes mellitus	1.89e-05	0.000237	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	1.88e-05	0.000236	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	1.87e-05	0.000235	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—ABCC8—type 1 diabetes mellitus	1.86e-05	0.000234	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	1.86e-05	0.000233	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—VAV1—type 1 diabetes mellitus	1.83e-05	0.000229	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	1.82e-05	0.000229	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—VAV1—type 1 diabetes mellitus	1.82e-05	0.000229	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CXCL10—type 1 diabetes mellitus	1.82e-05	0.000228	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—VAV1—type 1 diabetes mellitus	1.8e-05	0.000226	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CXCL10—type 1 diabetes mellitus	1.8e-05	0.000226	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—HBA1—type 1 diabetes mellitus	1.79e-05	0.000225	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—APOC3—type 1 diabetes mellitus	1.78e-05	0.000224	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—HBA1—type 1 diabetes mellitus	1.78e-05	0.000223	CbGpPWpGaD
Tolterodine—Hypersensitivity—Ramipril—type 1 diabetes mellitus	1.77e-05	0.0206	CcSEcCtD
Tolterodine—CYP2C9—Metabolism—APOC3—type 1 diabetes mellitus	1.76e-05	0.000222	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	1.75e-05	0.00022	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—GSTT1—type 1 diabetes mellitus	1.75e-05	0.00022	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—GSTT1—type 1 diabetes mellitus	1.73e-05	0.000218	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—CD80—type 1 diabetes mellitus	1.72e-05	0.000216	CbGpPWpGaD
Tolterodine—Asthenia—Ramipril—type 1 diabetes mellitus	1.72e-05	0.0201	CcSEcCtD
Tolterodine—CHRM1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	1.66e-05	0.000209	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—TYK2—type 1 diabetes mellitus	1.66e-05	0.000208	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.65e-05	0.000208	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CD80—type 1 diabetes mellitus	1.65e-05	0.000207	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.65e-05	0.000207	CbGpPWpGaD
Tolterodine—Diarrhoea—Ramipril—type 1 diabetes mellitus	1.64e-05	0.0191	CcSEcCtD
Tolterodine—CHRM2—Signaling by GPCR—TYK2—type 1 diabetes mellitus	1.64e-05	0.000206	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.63e-05	0.000205	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—INS—type 1 diabetes mellitus	1.63e-05	0.000205	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	1.6e-05	0.000201	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CD86—type 1 diabetes mellitus	1.59e-05	0.0002	CbGpPWpGaD
Tolterodine—Dizziness—Ramipril—type 1 diabetes mellitus	1.59e-05	0.0185	CcSEcCtD
Tolterodine—CHRM3—Signaling Pathways—CD86—type 1 diabetes mellitus	1.59e-05	0.000199	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.57e-05	0.000198	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CD86—type 1 diabetes mellitus	1.57e-05	0.000197	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.57e-05	0.000197	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—INS—type 1 diabetes mellitus	1.56e-05	0.000196	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.52e-05	0.000191	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.52e-05	0.00019	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—GCG—type 1 diabetes mellitus	1.51e-05	0.00019	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.51e-05	0.00019	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.51e-05	0.000189	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.51e-05	0.000189	CbGpPWpGaD
Tolterodine—Headache—Ramipril—type 1 diabetes mellitus	1.5e-05	0.0175	CcSEcCtD
Tolterodine—CHRM2—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.5e-05	0.000189	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.5e-05	0.000188	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.49e-05	0.000187	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	1.47e-05	0.000185	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.45e-05	0.000183	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.44e-05	0.00018	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.43e-05	0.00018	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.43e-05	0.000179	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.42e-05	0.000178	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.41e-05	0.000177	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.41e-05	0.000177	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.39e-05	0.000175	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.39e-05	0.000175	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—GCG—type 1 diabetes mellitus	1.39e-05	0.000175	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.39e-05	0.000175	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.39e-05	0.000174	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.38e-05	0.000174	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—GCG—type 1 diabetes mellitus	1.38e-05	0.000173	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.38e-05	0.000173	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.37e-05	0.000173	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.37e-05	0.000172	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.36e-05	0.000171	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—INS—type 1 diabetes mellitus	1.31e-05	0.000164	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—CAT—type 1 diabetes mellitus	1.28e-05	0.000161	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	1.24e-05	0.000156	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.21e-05	0.000152	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—IL2—type 1 diabetes mellitus	1.21e-05	0.000152	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—IL6—type 1 diabetes mellitus	1.2e-05	0.000151	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—ALB—type 1 diabetes mellitus	1.2e-05	0.000151	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—CAT—type 1 diabetes mellitus	1.18e-05	0.000148	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	1.17e-05	0.000147	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—CAT—type 1 diabetes mellitus	1.17e-05	0.000147	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	1.16e-05	0.000146	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CD80—type 1 diabetes mellitus	1.16e-05	0.000146	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.16e-05	0.000146	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—IL2—type 1 diabetes mellitus	1.16e-05	0.000146	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CD80—type 1 diabetes mellitus	1.16e-05	0.000145	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—IL6—type 1 diabetes mellitus	1.15e-05	0.000145	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—NOS3—type 1 diabetes mellitus	1.15e-05	0.000144	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CD80—type 1 diabetes mellitus	1.15e-05	0.000144	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	1.14e-05	0.000144	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—INS—type 1 diabetes mellitus	1.1e-05	0.000138	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—INS—type 1 diabetes mellitus	1.09e-05	0.000137	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—INS—type 1 diabetes mellitus	1.08e-05	0.000136	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.06e-05	0.000133	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.06e-05	0.000133	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.06e-05	0.000133	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.05e-05	0.000132	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.05e-05	0.000132	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.04e-05	0.000131	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.02e-05	0.000128	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—TYK2—type 1 diabetes mellitus	9.81e-06	0.000123	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—TYK2—type 1 diabetes mellitus	9.78e-06	0.000123	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—STAT3—type 1 diabetes mellitus	9.75e-06	0.000123	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—TYK2—type 1 diabetes mellitus	9.68e-06	0.000122	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—NOS3—type 1 diabetes mellitus	9.63e-06	0.000121	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—NOS3—type 1 diabetes mellitus	9.6e-06	0.000121	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—NOS3—type 1 diabetes mellitus	9.5e-06	0.000119	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—EGFR—type 1 diabetes mellitus	9.26e-06	0.000116	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	9.11e-06	0.000114	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—EGFR—type 1 diabetes mellitus	8.87e-06	0.000111	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—INS—type 1 diabetes mellitus	8.51e-06	0.000107	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CASP3—type 1 diabetes mellitus	8.17e-06	0.000103	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—IL2—type 1 diabetes mellitus	8.16e-06	0.000103	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CASP3—type 1 diabetes mellitus	8.15e-06	0.000102	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—IL2—type 1 diabetes mellitus	8.14e-06	0.000102	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—IL6—type 1 diabetes mellitus	8.12e-06	0.000102	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—IL6—type 1 diabetes mellitus	8.1e-06	0.000102	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CASP3—type 1 diabetes mellitus	8.07e-06	0.000101	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—IL2—type 1 diabetes mellitus	8.06e-06	0.000101	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—IL6—type 1 diabetes mellitus	8.02e-06	0.000101	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—INS—type 1 diabetes mellitus	7.83e-06	9.83e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—ALB—type 1 diabetes mellitus	7.8e-06	9.8e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—INS—type 1 diabetes mellitus	7.76e-06	9.74e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	7.71e-06	9.68e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—NOS3—type 1 diabetes mellitus	7.46e-06	9.37e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—ALB—type 1 diabetes mellitus	7.17e-06	9.01e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—IL6—type 1 diabetes mellitus	7.11e-06	8.94e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—ALB—type 1 diabetes mellitus	7.11e-06	8.93e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.87e-06	8.63e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—NOS3—type 1 diabetes mellitus	6.86e-06	8.62e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.85e-06	8.6e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—IL6—type 1 diabetes mellitus	6.81e-06	8.56e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—NOS3—type 1 diabetes mellitus	6.8e-06	8.55e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.78e-06	8.52e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—EGFR—type 1 diabetes mellitus	6.24e-06	7.84e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—EGFR—type 1 diabetes mellitus	6.22e-06	7.82e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—EGFR—type 1 diabetes mellitus	6.16e-06	7.74e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	5.12e-06	6.43e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—IL6—type 1 diabetes mellitus	4.8e-06	6.03e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—IL6—type 1 diabetes mellitus	4.78e-06	6.01e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—IL6—type 1 diabetes mellitus	4.74e-06	5.95e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	4.69e-06	5.89e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	4.49e-06	5.64e-05	CbGpPWpGaD
